Latest Impairment News

Page 27 of 61
Rewardle Holdings clarifies its complex relationship with CloudHolter and updates on Pepper Leaf loan litigation, addressing ASX concerns over financial reporting delays.
Sophie Babbage
Sophie Babbage
9 Sept 2025
Woolworths Group has confirmed its full-year earnings for 2025 met market expectations, responding comprehensively to ASX inquiries about potential material variances. The retailer’s underlying results closely matched analyst consensus, despite statutory impairments and restructuring costs.
Logan Eniac
Logan Eniac
9 Sept 2025
360 Capital Mortgage REIT has introduced a voluntary Distribution Reinvestment Plan allowing unitholders to reinvest monthly distributions into additional units at net asset value without transaction costs. This move aims to enhance investor returns while maintaining capital preservation and transparency.
Victor Sage
Victor Sage
8 Sept 2025
Rewardle Holdings has cleared a major compliance hurdle by releasing its preliminary report, spotlighting its strategic investment in cardiac MedTech firm CloudHolter and ongoing B2B2C platform development.
Sophie Babbage
Sophie Babbage
8 Sept 2025
Rewardle Holdings reported a modest revenue increase for FY25 but saw its loss more than double, driven by investments in AI-powered MedTech associate CloudHolter and expanded platform initiatives.
Sophie Babbage
Sophie Babbage
8 Sept 2025
Frontier Digital Ventures reported a 5% decline in revenue but a striking 71% jump in EBITDA for the first half of 2025, driven by margin expansion and operational efficiencies across its classifieds marketplaces in emerging regions.
Sophie Babbage
Sophie Babbage
8 Sept 2025
DGL Group Limited has issued a corrected FY25 financial presentation, revealing lower EBITDA and NPAT figures due to operational challenges and restructuring costs. Despite revenue growth, the company faces a modified audit opinion on inventory and outlines strategic cost-cutting and growth investments.
Victor Sage
Victor Sage
5 Sept 2025
PYC Therapeutics has completed dosing in its Phase 1 study of PYC-001 for Autosomal Dominant Optic Atrophy, showing strong safety and early signs of improved vision. The company plans to launch a global Phase 1/2 trial later this year.
Ada Torres
Ada Torres
5 Sept 2025
oOh!media has confirmed its half-year earnings for 2025 met market expectations, despite a significant non-cash impairment linked to the loss of a key Auckland Transport contract. The company maintains steady operational performance and updated guidance amid evolving market conditions.
Elise Vega
Elise Vega
2 Sept 2025
Collins Foods delivered record $1.5 billion revenue in FY25, pivoting to focus on KFC growth in Australia and Germany while exiting Taco Bell. Despite impairments and wage remediation costs, the company targets strong profit growth in FY26.
Victor Sage
Victor Sage
2 Sept 2025
Clime Investment Management has reported a strong FY25 profit turnaround, posting $2.1 million pretax and amortisation profit and declaring a fully franked dividend. The company outlines ambitious growth and margin targets for FY26 amid strategic restructuring and technology investments.
Claire Turing
Claire Turing
1 Sept 2025
Mayfield Childcare Limited reported a modest underlying EBITDA loss for the first half of 2025 amid occupancy challenges and acquisition underperformance. The company’s operational overhaul and targeted investments signal a cautious but hopeful recovery trajectory.
Victor Sage
Victor Sage
1 Sept 2025